Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion
Mercury Celebrates the Expansion of its Phoenix Production Facility
EverQuote Releases New White Paper Addressing Personal AI Agents and the Future of P&C Insurance Distribution
Teleskope Launches Kosmo, an AI Co-Pilot for Data Security Teams
StakePoint Becomes the First Solana Token Locker and Staking Platform to Fully Support PumpFun Tokens and StonkFun Tokens
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) — Biophytis (Euronext Growth Paris: ALBPS)…
Clinical proof of concept achieved for derazantinib monotherapy in FGFR2 gene fusion-positive iCCA 20.4% objective…
GENEVA, Switzerland and BOSTON, MA (February 10, 2021) – ObsEva SA (NASDAQ: OBSV; SIX:…
LAKE FOREST, Ill., Feb. 10, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
DUBLIN, Ireland and CHICAGO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Nes Ziona, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…
PHILADELPHIA, PA, Feb. 09, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (the “Company”), a clinical-stage…
LONDON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical…
Nes Ziona, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…
FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma…
LEXINGTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), a clinical stage…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb….
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Lille, France; Cambridge, MA; February 09, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
UNIONDALE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage…
PRESS RELEASE Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial…
Press Release – No. 7 / 2021 Copenhagen, DK and Boston, MA, February 9, 2021 – Zealand…
CANTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
U.S. FDA reviewing premarket approval (PMA) submission for LungFitTM PH to treat persistent pulmonary hypertension…